Prognostic model for esophagogastric variceal rebleeding after endoscopic treatment in liver cirrhosis: A Chinese multicenter study

doi:10.3748/wjg.v31.i2.100234

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1428)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

725

Figures (1-5)

107

Tables (1-3)

107

Sum=968

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

214

Sum=287

Publishing Process of This Article

Item

Count

Browse

Download

Sum=108

Jan 14, 2025 (publication date) through Mar 2, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jan 14, 2025; 31(2): 100234
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.100234

Full Size Figure Download Figure

Figure 5 Risk stratification for variceal rebleeding. A: Optimal thresholds for prognostic scores (using X-tile software); B and C: The Kaplan-Meier curves for the different risk groups in the derivation (B) and validation cohorts (C).

Citation: Zhan JY, Chen J, Yu JZ, Xu FP, Xing FF, Wang DX, Yang MY, Xing F, Wang J, Mu YP. Prognostic model for esophagogastric variceal rebleeding after endoscopic treatment in liver cirrhosis: A Chinese multicenter study. World J Gastroenterol 2025; 31(2): 100234
URL: https://www.wjgnet.com/1007-9327/full/v31/i2/100234.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i2.100234